Hoth Therapeutics, Inc.
HOTH
$0.8687
-$0.021-2.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.97M | 4.69M | 4.57M | 4.55M | 4.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.22M | 7.79M | 7.75M | 7.81M | 7.95M |
| Operating Income | -8.22M | -7.79M | -7.75M | -7.81M | -7.95M |
| Income Before Tax | -8.19M | -7.77M | -7.72M | -7.96M | -8.11M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.19 | -7.77 | -7.72 | -7.96 | -8.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.19M | -7.77M | -7.72M | -7.96M | -8.11M |
| EBIT | -8.22M | -7.79M | -7.75M | -7.81M | -7.95M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.34 | -1.46 | -1.75 | -2.08 | -2.50 |
| Normalized Basic EPS | -0.84 | -0.91 | -1.09 | -1.27 | -1.52 |
| EPS Diluted | -1.34 | -1.46 | -1.75 | -2.08 | -2.50 |
| Normalized Diluted EPS | -0.84 | -0.91 | -1.09 | -1.27 | -1.52 |
| Average Basic Shares Outstanding | 25.49M | 22.54M | 19.12M | 15.54M | 13.63M |
| Average Diluted Shares Outstanding | 25.49M | 22.54M | 19.12M | 15.54M | 13.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |